FERTIN PHARMA A/S: Financial statements 2019
CVR: 25834844
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
FERTIN PHARMA A/S (CVR 25834844) has filed annual accounts for 2019. In 2019, the company reported revenue of DKK 881,616,000 and a net result of DKK 81,301,000 compared with DKK 45,844,000 the year before. That is an increase of 8.5% compared with the year before. The profit margin was 9.2%. Equity in the 2019 report amounted to DKK 778,328,000. The solvency ratio was 41.1%. The company had 661 employees in the financial year.
- Revenue
- DKK 881,616,000
- Gross Profit
- DKK 190,774,000
- Profit/Loss
- DKK 81,301,000
- Equity
- DKK 778,328,000
- Total Assets
- DKK 1,894,241,000
- Employees
- 661
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | 881.6M | 190.8M | 81.3M | 778.3M | 661 |
| 2018 | 812.5M | 121.4M | 45.8M | 896M | 609 |
| 2017 | 867.7M | 208.5M | 106.4M | 770.5M | 572 |
| 2016 | 855.7M | 546.5M | 100.1M | 659.6M | 530 |
| 2015 | 800.7M | 467.8M | 64M | 560.9M | 543 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
As of September 1, 2019, Marianne Kirkegaard Knudsen has joined the board of directors of FERTIN PHARMA A/S.
As of September 1, 2019, Thomas Werner has left the board of directors of FERTIN PHARMA A/S.
FERTIN PHARMA A/S has published its annual report for 2018. Revenue came to DKK 812,500,000, and the net result was DKK 45,844,000.
As of May 15, 2019, Gitte Lorenzen has joined the board of directors of FERTIN PHARMA A/S.
As of May 15, 2019, Betina Tandrup Moslund has joined the board of directors of FERTIN PHARMA A/S.
As of May 15, 2019, Bente Brændshøj has joined the board of directors of FERTIN PHARMA A/S.
As of May 15, 2019, Peter Andreas Lund Dahl Jacobsen has joined the board of directors of FERTIN PHARMA A/S.
As of May 15, 2019, Carsten Skou has joined the board of directors of FERTIN PHARMA A/S.
As of May 15, 2019, Erik Bak Mortensen has left the board of directors of FERTIN PHARMA A/S.
As of May 15, 2019, Henrik Werner Lassen has left the board of directors of FERTIN PHARMA A/S.
About FERTIN PHARMA A/S
FERTIN PHARMA A/S is a Danish company of the type Aktieselskab based in Vejle, founded in 2001. The company is registered under the industry Fremstilling af andre fødevarer i.a.n.. The company was previously named JUT NR. 2128 A/S. The management consists of Michael Henrik Thomsen. The board consists of Christopher Beck Lambert (chair), Bo Korsgaard Jensen, Jovana Mejri and Michael Henrik Thomsen. The company is owned by Aspeya Inc.. The company has 959 employees (2026). In 2025, the company reported revenue of DKK 1,344,394,000 and a net result of DKK -280,841,000 compared with DKK -259,011,000 the year before. Equity in the 2025 report amounted to DKK 1,269,900,000.